Switching between anti-tumour necrosis factors: trying to get a handle on a complex issue

被引:64
作者
van Vollenhoven, Ronald F. [1 ]
机构
[1] Karolinska Univ Hosp, S-17176 Stockholm, Sweden
关键词
D O I
10.1136/ard.2007.069872
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:849 / 851
页数:3
相关论文
共 26 条
[11]   Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study [J].
Furst, Daniel E. ;
Gaylis, Norman ;
Bray, Vance ;
Olech, Ewa ;
Yocum, David ;
Ritter, Jeffrey ;
Weisman, Michael ;
Wallace, Daniel J. ;
Crues, John ;
Khanna, Dinesh ;
Eckel, Gregory ;
Yeilding, Newman ;
Callegari, Peter ;
Visvanathan, Sudha ;
Rojas, Jeannie ;
Hegedus, Ronald ;
George, Laura ;
Mamun, Khalid ;
Gilmer, Keith ;
Troum, Orrin .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (07) :893-899
[12]  
Gómez-Puerta JA, 2004, ANN RHEUM DIS, V63, P896
[13]   Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period [J].
Gomez-Reino, JJ ;
Carmona, L .
ARTHRITIS RESEARCH & THERAPY, 2006, 8 (01)
[14]  
Hansen KE, 2004, J RHEUMATOL, V31, P1098
[15]  
Haraoui B, 2004, J RHEUMATOL, V31, P2356
[16]  
HJARDEM E, 2007, ANN RHEUM DIS
[17]   Outcomes after switching from one anti-tumor necrosis factor α agent to a second anti-tumor necrosis factor α agent in patients with rheumatoid arthritis -: Results from a large UK national cohort study [J].
Hyrich, Kimme L. ;
Lunt, Mark ;
Watson, Kath D. ;
Symmons, Deborah P. M. ;
Silman, Alan J. .
ARTHRITIS AND RHEUMATISM, 2007, 56 (01) :13-20
[18]   Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects [J].
Iannone, Florenzo ;
Trotta, Francesco ;
Monteccuco, Carlomaurizio ;
Giacomelli, Roberto ;
Galeazzi, Mauro ;
Matucci-Cerinic, Marco ;
Ferri, Clodoveo ;
Cutolo, Maurizio ;
Bambara, Lisa Maria ;
Triolo, Giovanni ;
Ferraccioli, Gianfranco ;
Valentini, Gabriele ;
Lapadula, Giovanni .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (02) :249-252
[19]   Efficacy and safety of switching from infliximab to adalimumab: a comparative controlled study [J].
Nikas, SN ;
Voulgari, PV ;
Alamanos, Y ;
Papadopoulos, CG ;
Venetsanopoulou, AI ;
Georgiadis, AN ;
Drosos, AA .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (02) :257-260
[20]   Lack of efficacy of a third tumour necrosis factor α antagonist after failure of a soluble receptor and a monoclonal antibody [J].
Solau-Gervais, E. ;
Laxenaire, N. ;
Cortet, B. ;
Dubucquoi, S. ;
Duquesnoy, B. ;
Flipo, R.-M. .
RHEUMATOLOGY, 2006, 45 (09) :1121-1124